Cite
HARVARD Citation
Van den Bossche, J. et al. (2019). In vitro study of the Polo‐like kinase 1 inhibitor volasertib in non‐small‐cell lung cancer reveals a role for the tumor suppressor p53. Molecular oncology. 13 (5), pp. 1196-1213. [Online].